LimFlow is a medical company that develops a new solution for end-stage chronic limb ischemia (CLI) treatment. The inventiveness of the Company has led to a procedure that reimagines the anatomy, turning a vein into an artery and reversing flow to bring blood flow and oxygen back to starved ischemic legs. The novel LimFlow System employs a variety of proprietary technologies – including ultrasound catheters, a push valvulotome, and crossing and extension stents – to create a new and minimally-invasive option for “no option” CLI patients that may help them improve their lives and avoid amputation.
|Employees (est.) (Nov 2020)||24||(+5%)|
LimFlow total Funding
LimFlow latest funding size
Time since last funding
|3 years ago|
|Bpifrance, Sofinnova Partners, Balestier, French sovereign investment bank|
When was LimFlow founded?
LimFlow was founded in 2012.
Who are LimFlow key executives?
LimFlow's key executives are Dan Rose, Tim Lenihan and Sophie Humbert.
How many employees does LimFlow have?
LimFlow has 24 employees.
Who are LimFlow competitors?
Competitors of LimFlow include Cala Health, Photothera Labs and Acelity.
Where is LimFlow headquarters?
LimFlow headquarters is located at 95 Boulevard Pereire, Paris.
Where are LimFlow offices?
LimFlow has offices in Paris and Santa Clara.
How many offices does LimFlow have?
LimFlow has 2 offices.
Receive alerts for 300+ data fields across thousands of companies